Partner
James Dahlman
Co-Founder and Chief Scientific Officer, Readout Capital
- Firm
- Readout Capital
- Title
- Co-Founder and Chief Scientific Officer
- Role
- Cofounder
Record updated 1 October 2026
About
Dr. Dahlman is responsible for all medical and scientific diligence at Readout Capital. He previously worked with Mr. Smith as an outside consultant at Lion Point Capital and was on the biotech investment team at Google Ventures. His inventions have been licensed to over 60 companies. He is also a tenured professor in the Department of Biomedical Engineering at Georgia Tech and Emory Medical School, where his lab spun out two successful biotechs. He received his Ph.D. in Medical Engineering and Medical Physics from MIT and Harvard Medical School.
Is this you? Remove my profile